Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Gastric or Rectal Cancers
NCT00254436Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2001
- Primary completion
- Jun 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia comparing Epoetin Alfa with Placebo (2 arms). Primary endpoints: Number of Patients with Reduction in Red Blood Cell Transfusions at 2 years and Patient Iron Levels. Started Oct 2001; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00254436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254436.